Major drug interactions
This medicine may have important interactions with other medicines.
Leaflet XEFO 8mg / 2ml powder and solvent for solution for injection
- Product code:
- W62179001
- Quantity:
- 10
- Indicated for:
- pain and inflammation
- Route of administration:
- injectable
- Substance:
- lornoxicam (nonsteroidal anti-inflammatory drug)
- ATC
- M01AC05 — Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Oxicams
Precautions:
Nephrotoxicity
This medicine may affect the kidneys.
Pregnancy warning
Use during pregnancy only on medical advice.
Bleeding risk
This medicine may increase the risk of bleeding.
Ulcer / gastrointestinal bleeding
This medicine may increase the risk of ulcer or gastrointestinal bleeding.
Lornoxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to treat acute and chronic pain, as well as inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, or other musculoskeletal disorders. It is also used for the relief of postoperative or post-traumatic pain.
Lornoxicam works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), reducing the production of prostaglandins, substances involved in inflammation, pain, and fever. It is available in tablet or injectable solution form.
Side effects may include nausea, stomach pain, diarrhea, dizziness, heartburn, or, in rare cases, gastric ulcers, gastrointestinal bleeding, or allergic reactions. Long-term use or high doses may increase the risk of cardiovascular events and kidney damage. It is important to take the medication as prescribed by a doctor, and patients with a history of gastric or cardiovascular conditions should be closely monitored.
Lornoxicam works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), reducing the production of prostaglandins, substances involved in inflammation, pain, and fever. It is available in tablet or injectable solution form.
Side effects may include nausea, stomach pain, diarrhea, dizziness, heartburn, or, in rare cases, gastric ulcers, gastrointestinal bleeding, or allergic reactions. Long-term use or high doses may increase the risk of cardiovascular events and kidney damage. It is important to take the medication as prescribed by a doctor, and patients with a history of gastric or cardiovascular conditions should be closely monitored.
General data about XEFO 8mg / 2ml
- Substance:
- lornoxicam
- Date of latest medicines list:
- 01-07-2020
- Product code:
- W62179001
- Concentration:
- 8mg / 2ml
- Pharmaceutical form:
- powder and solvent for solution for injection
- Packing volume:
- 2ml
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for lornoxicam
Concentrations available for lornoxicam
- 4mg
- 8mg
- 8mg/2ml